Una guía para la primera consulta | 07 DIC 15

Síntomas neurológicos médicamente inexplicables

Síntomas desconcertantes en su presentación que pueden poner a prueba a los médicos más expertos. Principios heurísticos básicos para su tratamiento.
INDICE:  1. Página 1 | 2. Referencias

1. Steinbrecher N, Koerber S, Frieser D, et al. The prevalence of medically unexplained symptoms in primary care. Psychosomatics. 2011;52:263-271.
2. Morriss R, Lindson N, Coupland C, et al. Estimating the prevalence of medically unexplained symptoms from primary care records. Public Health. 2012;126:846-854.
3. Nimnuan C, Hotopf M, Wessely S. Medically unexplained symptoms: an epidemiological study in seven specialities. J Psychosom Res. 2001;51:361-367.
4. Duncan R, Razvi S,Mulhern S. Newly presenting psychogenic nonepileptic seizures: incidence, population characteristics, and early outcome from a prospective audit of a first seizure clinic. Epilepsy Behav. 2011;20:308-311.
5. Sigurdardottir KR, Olafsson E. Incidence of psychogenic seizures in adults: a population-based study in Iceland. Epilepsia. 1998;39:749-752.
6. Behrouz R, Benbadis SR. Psychogenic pseudostroke. J Stroke Cerebrovasc Dis. 2014;23:e243-e248.
7. Peritogiannis V, Zafiris S, Pappas D, et al. Conversion pseudodementia in the elderly: a review of the literature with case presentation. Psychogeriatrics. 2008;8:24-31.
8. Miyasaki JM, Sa DS, Galvez-Jimenez N, et al. Psychogenic movement disorders. Can J Neurol Sci. 2003;30(Suppl 1):S94-S100. 
9. Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry. 2005;62:903-910.
10. Hallett M. Psychogenic movement disorders: a crisis for neurology. Curr Neurol Neurosci Rep. 2006;6:269-271.
11. Stone J, Carson A. Movement disorders: psychogenic movement disorders: what do neurologists do? Nat Rev Neurol. 2009;5:415-416.
12. Hilderink PH, Collard R, Rosmalen JG, et al. How does ageing affect the impact of medically unexplained symptoms and medically explained symptoms on health-related quality of life? Int J Geriatr Psychiatry. 2015;30:737-743.
13. Micale MS. Charcot and the idea of hysteria in the male: gender, mental science, and medical diagnosis in late nineteenth-century France. Med Hist. 1990;34:363-411. 14. Shorvon S. Fashion and cult in neuroscience—the case of hysteria. Brain. 2007;130:3342-3348.
15. Cosmacini G. The Long Art: The History of Medicine from Antiquity to the Present. 00. Rome: Oxford University Press; 1997.
16. Sigerist H. Primitive and Archaic Medicine. New York: Oxford University Press; 1951.
17. de Marneffe D. Looking and listening: the construction of clinical knowledge in Charcot and Freud. Signs. 1991;17:71-111.
18. Hunter D. Hysteria, psychoanalysis, and feminism: the case of Anna O. Fem Stud. 1983;9:464-488.
19. Webster R. Why Freud Was Wrong: Sin, Science and Psychoanalysis. New York: HarperCollins/Basic Books; 1995.
20. Bogousslavsky J, ed. Hysteria: The Rise of an Enigma. Basel: Karger; 2014.
21. Kranick SM, Gorrindo T, Hallett M. Psychogenic movement disorders and motor conversion: a roadmap for collaboration between neurology and psychiatry. Psychosomatics. 2011;52:109-116.
22. Peckham EL, Hallett M. Psychogenic movement disorders. Neurol Clin. 2009;27:801-819, vii.
23. Carton S, Thompson PJ, Duncan JS. Non-epileptic seizures: patients’ understanding and reaction to the diagnosis and impact on outcome. Seizure. 2003;12:287-294.
24. Stone J, Carson A. Functional neurologic symptoms: assessment and management. Neurol Clin. 2011;29:1-18, vii.
25. Hinson VK, Haren WB. Psychogenic movement disorders. Lancet Neurol. 2006;5:695-700.
26. Stone J. The bare essentials: functional symptoms in neurology. Pract Neurol. 2009;9:179-189.
27. Stone J, Carson A, Sharpe M. Functional symptoms in neurology: management. J Neurol Neurosurg Psychiatry. 2005;76(Suppl 1): i13-i21.
28. Stone J, Hewett R, Carson A, et al. The ‘disappearance’ of hysteria: historical mystery or illusion? J Roy Soc Med. 2008;101:12-18.
29. Stone J, Smyth R, Carson A, et al. Systematic review of misdiagnosis of conversion symptoms and “hysteria”. BMJ. 2005;331:989.
30. Abbass A, Kisely S, Kroenke K. Short-term psychodynamic psychotherapy for somatic disorders. Systematic review and meta-analysis of clinical trials. Psychother Psychosom. 2009;78:265-274.
31. Edwards MJ, Stone J, Nielsen G. Physiotherapists and patients with functional (psychogenic) motor symptoms: a survey of attitudes and interest. J Neurol Neurosurg Psychiatry. 2012;83:655-658.
32. Edwards MJ, Bhatia KP. Functional (psychogenic) movement disorders: merging mind and brain. Lancet Neurol. 2012;11:250-260.
33. Jankovic J, Vuong KD, Thomas M. Psychogenic tremor: long-term outcome. CNS Spectr. 2006;11:501-508.
34. Stone J, Sharpe M, Rothwell PM, et al. The 12 year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry. 2003;74:591-596.
35. Sharpe M, Stone J, Hibberd C, et al. Neurology out-patients with symptoms unexplained by disease: illness beliefs and financial benefits predict 1-year outcome. Psychol Med. 2010;40:689-698.
36. Stone J, Carson A, Duncan R, et al. Symptoms ‘unexplained by organic disease’ in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain. 2009;132(Pt 10):2878-2888



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024